JP2016086744A5 - - Google Patents

Download PDF

Info

Publication number
JP2016086744A5
JP2016086744A5 JP2014225642A JP2014225642A JP2016086744A5 JP 2016086744 A5 JP2016086744 A5 JP 2016086744A5 JP 2014225642 A JP2014225642 A JP 2014225642A JP 2014225642 A JP2014225642 A JP 2014225642A JP 2016086744 A5 JP2016086744 A5 JP 2016086744A5
Authority
JP
Japan
Prior art keywords
protein
gene encoding
genome
viral vector
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014225642A
Other languages
English (en)
Japanese (ja)
Other versions
JP6854461B2 (ja
JP2016086744A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2014225642A external-priority patent/JP6854461B2/ja
Priority to JP2014225642A priority Critical patent/JP6854461B2/ja
Priority to EP15857426.9A priority patent/EP3216868A4/en
Priority to KR1020177015408A priority patent/KR20200066748A/ko
Priority to PCT/JP2015/081145 priority patent/WO2016072446A1/ja
Priority to US15/523,547 priority patent/US20170304430A1/en
Priority to CN201580068057.8A priority patent/CN107109436A/zh
Publication of JP2016086744A publication Critical patent/JP2016086744A/ja
Publication of JP2016086744A5 publication Critical patent/JP2016086744A5/ja
Publication of JP6854461B2 publication Critical patent/JP6854461B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014225642A 2014-11-05 2014-11-05 ウイルスベクター、ｉＰＳ細胞の作製方法およびコンストラクト Active JP6854461B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2014225642A JP6854461B2 (ja) 2014-11-05 2014-11-05 ウイルスベクター、ｉＰＳ細胞の作製方法およびコンストラクト
US15/523,547 US20170304430A1 (en) 2014-11-05 2015-11-05 Virus vector, cell, and construct
KR1020177015408A KR20200066748A (ko) 2014-11-05 2015-11-05 바이러스 벡터, 세포 및 작제물
PCT/JP2015/081145 WO2016072446A1 (ja) 2014-11-05 2015-11-05 ウイルスベクター、細胞およびコンストラクト
EP15857426.9A EP3216868A4 (en) 2014-11-05 2015-11-05 Virus vector, cell, and construct
CN201580068057.8A CN107109436A (zh) 2014-11-05 2015-11-05 病毒载体、细胞及构建体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014225642A JP6854461B2 (ja) 2014-11-05 2014-11-05 ウイルスベクター、ｉＰＳ細胞の作製方法およびコンストラクト

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019113463A Division JP2019170393A (ja) 2019-06-19 2019-06-19 ｉＰＳ細胞の作製方法

Publications (3)

Publication Number Publication Date
JP2016086744A JP2016086744A (ja) 2016-05-23
JP2016086744A5 true JP2016086744A5 (enExample) 2017-12-21
JP6854461B2 JP6854461B2 (ja) 2021-04-07

Family

ID=55909170

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014225642A Active JP6854461B2 (ja) 2014-11-05 2014-11-05 ウイルスベクター、ｉＰＳ細胞の作製方法およびコンストラクト

Country Status (6)

Country Link
US (1) US20170304430A1 (enExample)
EP (1) EP3216868A4 (enExample)
JP (1) JP6854461B2 (enExample)
KR (1) KR20200066748A (enExample)
CN (1) CN107109436A (enExample)
WO (1) WO2016072446A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3074003B1 (en) 2013-11-26 2023-01-11 Zoetis Services LLC Compositions for induction of immune response
JP7462863B2 (ja) * 2019-04-15 2024-04-08 国立感染症研究所長 組換え麻疹ウイルスの増殖方法及び宿主細胞
CN110904232B (zh) * 2019-12-12 2022-05-27 上海东方肝胆外科医院 评估索拉非尼疗效的分子标记及其检测试剂盒
EP4455290A4 (en) * 2021-12-28 2025-11-26 Japan Chem Res Fusion protein of an anti-transferrin receptor antibody and a bioactive protein for safe gene therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS602058A (ja) 1983-06-15 1985-01-08 Mitsubishi Electric Corp 電機子の製造方法
US20030170897A1 (en) * 2000-06-27 2003-09-11 Enyu Imai Virus vector for transferring gene into renal cells
WO2007007921A1 (ja) * 2005-07-13 2007-01-18 Kyushu University, National University Corporation 分節ゲノム型組換えモノネガウイルスベクター
DK2322611T3 (en) * 2008-07-16 2016-09-05 Ip Pharma Co Ltd A process for producing reprogrammed cells using chromosomally non-integrated viral vector
CN103189508B (zh) * 2010-08-30 2016-08-10 生物载体株式会社 用于诱导多能性干细胞的组合物及其用途
WO2012063817A1 (ja) * 2010-11-09 2012-05-18 独立行政法人産業技術総合研究所 末梢血単球由来多能性幹細胞作製方法
AU2014324233B2 (en) * 2013-09-24 2020-07-23 Id Pharma Co., Ltd. Method for improving efficiency of inducing pluripotent stem cell

Similar Documents

Publication Publication Date Title
MX391337B (es) Sistemas de replicón de arterivirus recombinantes y usos de estos.
BR112018011881A2 (pt) proteínas capsidiais modificadas para liberação aumentada de vetores de parvovírus
MX390848B (es) Factor ix modificado, y composiciones, metodos y usos para la transferencia de genes a celulas, organos y tejidos.
MX2016010649A (es) Vector de virus adeno-asociado.
MX2019004499A (es) Sistemas de replicón de virus recombinante y usos de estos.
EA201492202A1 (ru) Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
CL2019003842A1 (es) Vectores virales recombinantes con tropismo modificado y usos de estos para la introducción dirigida de material genético a células humanas.
MX2018005392A (es) Acidos nucleicos modificados dirigidos a acidos nucleicos.
PE20160188A1 (es) Variantes aav y composiciones, metodos y usos para transferencia de gen a celulas, organos y tejidos
MX392639B (es) Vectores virales recombinantes para la integración de transgenes
WO2015168547A3 (en) In vivo gene engineering with adenoviral vectors
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
MX2019002938A (es) Mutaciones estebilizantes de trimeros de proteinas de la envoltura del vih.
EA201891001A1 (ru) Вакцины на основе нуклеиновых кислот против вируса ветряной оспы (vzv)
BR112016017736A2 (pt) métodos e produtos para produção e distribuição de ácido nucleico
BR112016016937A2 (pt) Célula adaptada a suspensão isolada transduzida ou transfectada com um ácido nucleico heterólogo, porção ligada a membrana, porção ligada a membrana da célula, pluralidade de células adaptadas a suspensão isoladas, porção ligada à membrana de uma célula adaptada a suspensão isolada, partículas semelhantes a vírus ou vírus produzidas pela célula, vírus isolado, partícula semelhante a vírus isolada, pluralidade de vírus isolados, pluralidade de partículas semelhantes a vírus isoladas, ácido nucleico recombinante, células adaptadas a suspensão isoladas, célula adaptada a suspensão isolada transduzida ou transfectada com um ácido nucleico heterólogo, célula adaptada a suspensão isolada transduzida por ou transfectada com um vírus, ácido nucleico recombinante, método de identificação de um epítopo de célula t
JP2016086744A5 (enExample)
JP2016500260A5 (enExample)
MX375778B (es) Variantes mejoradas de enzimas.
EA202190469A1 (ru) Способы оценки интегрированных нуклеиновых кислот
CN109937252A (zh) 重组dna聚合酶
PE20170941A1 (es) Genes de tolerancia a herbicidas y metodos para usar los mismos
JP2016519575A5 (enExample)
CO2017011431A2 (es) Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina
MX374934B (es) Marcador de seleccion novedoso para transfeccion celular y produccion de proteinas.